ID   BJAB-L-YFP
AC   CVCL_YY30
SY   B-L-YFP; BJAB-YFP-LANA-Flag
DR   cancercelllines; CVCL_YY30
DR   Kerafast; ENR001
DR   Wikidata; Q98125572
RX   PubMed=29416688;
CC   Population: African; Kenyan.
CC   Characteristics: Transduced with a pLVx-AcYFP-C1-LANA-FLAG construct.
CC   Virology: EBV-negative.
CC   Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.His193Arg (c.578A>G); ClinVar=VCV000184979; Zygosity=Unspecified (from parent cell line).
CC   Transfected with: UniProtKB; Q9QR71; Human herpesvirus 8 type P LANA1.
CC   Transfected with: UniProtKB; P42212; YFP (modified GFP at G-65, L-68, A-72, Y-203 and L-231).
CC   Transfected with: UniProtKB; P13249; S.alboniger pac (PuroR).
CC   Derived from site: In situ; Groin; UBERON=UBERON_0008337.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5711 ! BJAB
SX   Female
AG   5Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 05-10-23; Version: 8
//
RX   PubMed=29416688; DOI=10.18632/oncotarget.23456;
RA   Thakker S., Strahan R.C., Scurry A.N., Uppal T., Verma S.C.;
RT   "KSHV LANA upregulates the expression of epidermal growth factor like
RT   domain 7 to promote angiogenesis.";
RL   Oncotarget 9:1210-1228(2018).
//